Taiwan Liposome Company, Ltd.
They are a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of best-in-class novel nanomedicines that combine our proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).
$7.46 - $7.46
Cantor, CLSA, H.C. Wainwright & Co., Janney Montgomery Scott, Laidlaw & Company (UK) Ltd.
To view the prospectus for Taiwan Liposome Company, Ltd. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277